TUMOR-SPECIFIC ACCUMULATION OF I-125 LABELED MOUSE-HUMAN CHIMERIC ANTI-CEA ANTIBODY IN A XENOGRAFTED HUMAN CANCER MODEL DEMONSTRATED BY WHOLE-BODY AUTORADIOGRAPHY AND IMMUNOSTAINING
M. Haruno et al., TUMOR-SPECIFIC ACCUMULATION OF I-125 LABELED MOUSE-HUMAN CHIMERIC ANTI-CEA ANTIBODY IN A XENOGRAFTED HUMAN CANCER MODEL DEMONSTRATED BY WHOLE-BODY AUTORADIOGRAPHY AND IMMUNOSTAINING, Nuclear medicine and biology, 23(6), 1996, pp. 821-826
Whole-body autoradiography (WEAR) was used to study the biodistributio
n of I-125-labeled mouse-human chimeric antibody (Ch F11-39) to carcin
oembryonic antigen (CEA) in athymic nude mice bearing the CEA-producin
g MKN-45 human gastric carcinoma xenografts. Significantly high uptake
of I-125-Ch F11-39 in the tumors obtained by tissue-counting techniqu
e was confirmed by WEAR of mice of 12, 24, 48, and 96 h postinjection
of I-125 Ch F11-39. When compared with histochemical or immunohistoche
mical staining results of the tumor tissue sections, imaging profiles
of I-125-Ch F11-39 obtained by WBARs were topographically correlated w
ith histopathological findings of tissues and immunohistochemical loca
lization of CEA in the tumor tissues, indicating that the accumulation
of I-125-Ch F11-39 at the tumor site is based on its specificity for
CEA. These results demonstrate that this chimeric antibody may serve a
s a potential useful diagnostic and/or therapeutic reagent for human C
EA-producing cancers.